We are live on !
Find out more
Brookmont Capital Management Portfolio holdings
AUM
$176M
Turnover
10.61%
1-Year Est. Return
1.49%
This Fund
S&P 500
This Quarter Est. Return
-5.59%
1 Year Est. Return
-1.49%
3 Year Est. Return
+32.24%
5 Year Est. Return
+38.13%
10 Year Est. Return
+189.47%
AUM
$176M
AUM Growth
-$10.4M
(-5.6%)
Cap. Flow
+$3.53M
Cap. Flow % of AUM
Cap. Flow %
2%
Top 10 Holdings %
Top 10 Hldgs %
51.4%
Holding
66
New
5
Increased
42
Reduced
15
Closed
2
Avg Time Held
6.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
4.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$2.92M |
| 2 |
Xylem
XYL
|
+$1.71M |
| 3 |
Kroger
KR
|
+$1.45M |
| 4 |
Solstice Advanced Materials
SOLS
|
+$1.3M |
| 5 |
Procter & Gamble
PG
|
+$1.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$2.01M |
| 2 |
ConocoPhillips
COP
|
+$1.92M |
| 3 |
JPMorgan Chase
JPM
|
+$1.16M |
| 4 |
Shell
SHEL
|
+$1.07M |
| 5 |
Eastman Chemical
EMN
|
+$1.07M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 28.6% |
| 2 | Technology | 14.83% |
| 3 | Financials | 11.55% |
| 4 | Healthcare | 10.5% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Home Depot
HD
$343B
| $46.2M | 26.24% |
162,289
-225
| -0.1% | -$73.9K |
2013 Q2
53 quarters
|
|
2
Microsoft
MSFT
$3.94T
| $6.44M | 3.66% |
12,558
+171
| +1% | +$79.1K |
2017 Q1
38 quarters
|
|
3
Gilead Sciences
GILD
$207B
| $5.65M | 3.21% |
37,928
+91
| +0.2% | +$12.8K |
2017 Q1
38 quarters
|
|
4
Analog Devices
ADI
$176B
| $5.26M | 2.99% |
13,252
+55
| +0.4% | +$20.7K |
2014 Q4
47 quarters
|
|
|
5
Procter & Gamble
PG
$383B
| $4.72M | 2.68% |
32,483
+8,309
| +34% | +$1.22M |
2013 Q2
53 quarters
|
|
|
6
JPMorgan Chase
JPM
$888B
| $4.7M | 2.67% |
14,212
-3,305
| -19% | -$1.16M |
2013 Q2
53 quarters
|
|
|
7
Shell
SHEL
$281B
| $4.59M | 2.61% |
48,332
-11,862
| -20% | -$1.07M |
2022 Q2
17 quarters
|
|
8
AstraZeneca
AZN
$289B
| $4.4M | 2.5% |
27,272
+836
| +3% | +$139K |
2024 Q2
9 quarters
|
|
9
Abbott
ABT
$190B
| $4.39M | 2.49% |
44,381
+6,918
| +18% | +$722K |
2013 Q2
53 quarters
|
|
10
L3Harris
LHX
$48.4B
| $4.12M | 2.34% |
17,382
+155
| +0.9% | +$42.2K |
2019 Q3
28 quarters
|
|
11
Qnity Electronics Inc
Q
$24.5B
| $3.81M | 2.17% |
30,308
+171
| +0.6% | +$22.4K |
2025 Q4
3 quarters
|
|
12
Wells Fargo
WFC
$252B
| $3.77M | 2.14% |
47,122
-2,062
| -4% | -$178K |
2013 Q2
53 quarters
|
|
13
Johnson & Johnson
JNJ
$665B
| $3.73M | 2.12% |
14,095
-154
| -1% | -$40.6K |
2013 Q2
53 quarters
|
|
14
Arthur J. Gallagher & Co
AJG
$72.2B
| $3.54M | 2.01% |
15,517
+96
| +0.6% | +$24.1K |
2013 Q2
53 quarters
|
|
15
Equinix
EQIX
$100B
| $3.26M | 1.85% |
3,224
+10
| +0.3% | +$10.4K |
2024 Q1
10 quarters
|
|
16
McDonald's
MCD
$196B
| $3.22M | 1.83% |
13,923
+25
| +0.2% | +$6.58K |
2013 Q2
53 quarters
|
|
17
NetEase
NTES
$82.9B
| $3.11M | 1.77% |
25,645
+131
| +0.5% | +$16.3K |
2025 Q4
3 quarters
|
|
18
Honeywell
HON
$69.7B
| $3.08M | 1.75% |
14,623
+4,476
| +44% | +$999K |
2014 Q4
47 quarters
|
|
|
19
Solstice Advanced Materials
SOLS
$9.12B
| $2.98M | 1.69% |
52,918
+21,376
| +68% | +$1.3M |
2025 Q4
3 quarters
|
|
|
20
Xylem
XYL
$22.4B
| $2.94M | 1.67% |
28,999
+14,904
| +106% | +$1.71M |
2026 Q2
1 quarter
|
|
21
TE Connectivity
TEL
$59.5B
| $2.9M | 1.65% |
13,749
+74
| +0.5% | +$15.3K |
2026 Q1
2 quarters
|
|
22
DuPont de Nemours
DD
$19.4B
| $2.89M | 1.64% |
22,253
+6,189
| +39% | +$842K |
2017 Q3
36 quarters
|
|
|
23
Linde
LIN
$237B
| $2.82M | 1.61% |
+5,950
| New | +$2.92M |
2026 Q3
0 quarters
|
|
24
Bank of America
BAC
$341B
| $2.7M | 1.53% |
49,551
-13,856
| -22% | -$844K |
2020 Q2
25 quarters
|
|
25
Waste Management
WM
$93.9B
| $2.65M | 1.5% |
12,979
+69
| +0.5% | +$15.5K |
2025 Q3
4 quarters
|
|
Similar funds
Brookmont Capital Management's Q3 2026 Portfolio in Review
As of Q3 2026, Brookmont Capital Management held 66 positions worth $176M, down 5.6% from $186M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Brookmont Capital Management's Q3 2026 filing shows 5 new, 42 increased, 15 reduced and 2 closed positions. Its largest new stake was Linde: 5,950 shares worth $2.82M. The largest sale was PepsiCo, an estimated $2.01M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Brookmont Capital Management's largest Q3 2026 buy was Linde: 5,950 shares worth $2.82M.
- Brookmont Capital Management added most to Xylem in Q3 2026, an estimated $1.71M increase.
- Brookmont Capital Management's biggest Q3 2026 reduction was ConocoPhillips, cutting an estimated $1.92M.
- Brookmont Capital Management fully exited PepsiCo in Q3 2026, selling an estimated $2.01M.
- Brookmont Capital Management's ten largest holdings make up 51% of its $176M portfolio in Q3 2026.
- Brookmont Capital Management opened 5 new positions and closed 2 in Q3 2026.
- Brookmont Capital Management's portfolio value fell 5.6% quarter-over-quarter to $176M.
Based on Brookmont Capital Management's 13F filing for Q3 2026, filed 23 Oct 2026.